LBP, Human, mAb 1C7 - HM2044-100UG

Quantity
100 µg
Catalog #
HM2044-100UG
481,00 €
The monoclonal antibody 1C7 reacts highly specific with human natural and recombinant LBP. Crossreactions with LBP of other species are not observed. The antibody binds poorly to LBP-LPS complexes: it interacts with the LPS binding site. LPS binding protein (LBP) is an approximately 60 kDa acute phase protein that is produced by hepatocytes. This protein strongly binds to LPS and has been shown to play an important role in the handling of LPS by the host. A number of functions of LBP have been reported. First, LBP transfers LPS to the LPS receptor CD14 on mononuclear phagocytes, leading to an 100-1,000 fold increased sensitivity of the cells to LPS. Furthermore, LBP can enhance the response of CD14 negative cells by acceleration of LPS binding to soluble CD14, a complex that stimulates these cells. Next, LBP transfers LPS into High Density Lipoprotein (HDL), which effectively neutralizes its biological potency. LBP was demonstrated to protect mice from septic shock caused by LPS or gram negative bacteria.
Weitere Informationen
Datasheet URL https://www.hycultbiotech.com/wp-content/uploads/2022/06/coa-tds_hm2044-100ug.pdf
Quantity 100 µg
Quantity 100 µg
Species Human
Application Functional studies, Immuno assays, Immuno precipitation
Precautions For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and Federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result with the use of or derivation of this product.
Disease Infectious diseases
Applications
Application: Functional studies Immuno assays Immuno precipitation

Newsletter
abonnieren

15% Rabatt

erhalten